TY - JOUR AU - Motzer, R. J. AU - Escudier, B. AU - McDermott, D. F. AU - George, S. AU - Hammers, H. J. AU - Srinivas, S. PY - 2015 DA - 2015// TI - Nivolumab versus Everolimus in advanced renal-cell carcinoma JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1510665 DO - 10.1056/NEJMoa1510665 ID - Motzer2015 ER - TY - JOUR AU - Larkin, J. AU - Chiarion-Sileni, V. AU - Gonzalez, R. AU - Grob, J. J. AU - Cowey, C. L. AU - Lao, C. D. PY - 2015 DA - 2015// TI - Combined Nivolumab and Ipilimumab or monotherapy in untreated melanoma JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1504030 DO - 10.1056/NEJMoa1504030 ID - Larkin2015 ER - TY - JOUR AU - Borghaei, H. AU - Paz-Ares, L. AU - Horn, L. AU - Spigel, D. R. AU - Steins, M. AU - Ready, N. E. PY - 2015 DA - 2015// TI - Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung Cancer JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1507643 DO - 10.1056/NEJMoa1507643 ID - Borghaei2015 ER - TY - JOUR AU - Brahmer, J. AU - Reckamp, K. L. AU - Baas, P. AU - Crino, L. AU - Eberhardt, W. E. AU - Poddubskaya, E. PY - 2015 DA - 2015// TI - Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung Cancer JO - N Engl J Med VL - 373 UR - https://doi.org/10.1056/NEJMoa1504627 DO - 10.1056/NEJMoa1504627 ID - Brahmer2015 ER - TY - STD TI - Harrington KJ, Ferris RL, Blumenschein G, Jr., Colevas AD, Fayette J, Licitra L, et al. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. Lancet Oncol 2017;18(8):1104–1115. ID - ref5 ER - TY - JOUR AU - Bellmunt, J. AU - de Wit, R. AU - Vaughn, D. J. AU - Fradet, Y. AU - Lee, J. L. AU - Fong, L. PY - 2017 DA - 2017// TI - Pembrolizumab as second-line therapy for advanced urothelial carcinoma JO - N Engl J Med VL - 376 UR - https://doi.org/10.1056/NEJMoa1613683 DO - 10.1056/NEJMoa1613683 ID - Bellmunt2017 ER - TY - JOUR AU - Sharma, P. AU - Allison, J. P. PY - 2015 DA - 2015// TI - Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential JO - Cell VL - 161 UR - https://doi.org/10.1016/j.cell.2015.03.030 DO - 10.1016/j.cell.2015.03.030 ID - Sharma2015 ER - TY - JOUR AU - Topalian, S. L. AU - Drake, C. G. AU - Pardoll, D. M. PY - 2015 DA - 2015// TI - Immune checkpoint blockade: a common denominator approach to cancer therapy JO - Cancer Cell VL - 27 UR - https://doi.org/10.1016/j.ccell.2015.03.001 DO - 10.1016/j.ccell.2015.03.001 ID - Topalian2015 ER - TY - JOUR AU - Chen, D. S. AU - Mellman, I. PY - 2017 DA - 2017// TI - Elements of cancer immunity and the cancer-immune set point JO - Nature VL - 541 UR - https://doi.org/10.1038/nature21349 DO - 10.1038/nature21349 ID - Chen2017 ER - TY - JOUR AU - Chen, L. AU - Flies, D. B. PY - 2013 DA - 2013// TI - Molecular mechanisms of T cell co-stimulation and co-inhibition JO - Nat Rev Immunol VL - 13 UR - https://doi.org/10.1038/nri3405 DO - 10.1038/nri3405 ID - Chen2013 ER - TY - JOUR AU - Valero-Pacheco, N. AU - Arriaga-Pizano, L. AU - Ferat-Osorio, E. AU - Mora-Velandia, L. M. AU - Pastelin-Palacios, R. AU - Villasis-Keever, M. A. PY - 2013 DA - 2013// TI - PD-L1 expression induced by the 2009 pandemic influenza a(H1N1) virus impairs the human T cell response JO - Clin Dev Immunol VL - 2013 UR - https://doi.org/10.1155/2013/989673 DO - 10.1155/2013/989673 ID - Valero-Pacheco2013 ER - TY - JOUR AU - Erickson, J. J. AU - Gilchuk, P. AU - Hastings, A. K. AU - Tollefson, S. J. AU - Johnson, M. AU - Downing, M. B. PY - 2012 DA - 2012// TI - Viral acute lower respiratory infections impair CD8+ T cells through PD-1 JO - J Clin Invest VL - 122 UR - https://doi.org/10.1172/JCI62860 DO - 10.1172/JCI62860 ID - Erickson2012 ER - TY - JOUR AU - McNally, B. AU - Ye, F. AU - Willette, M. AU - Flano, E. PY - 2013 DA - 2013// TI - Local blockade of epithelial PDL-1 in the airways enhances T cell function and viral clearance during influenza virus infection JO - J Virol VL - 87 UR - https://doi.org/10.1128/JVI.02423-13 DO - 10.1128/JVI.02423-13 ID - McNally2013 ER - TY - JOUR AU - Dirks, J. AU - Egli, A. AU - Sester, U. AU - Sester, M. AU - Hirsch, H. H. PY - 2013 DA - 2013// TI - Blockade of programmed death receptor-1 signaling restores expression of mostly proinflammatory cytokines in anergic cytomegalovirus-specific T cells JO - Transpl Infect Dis VL - 15 UR - https://doi.org/10.1111/tid.12025 DO - 10.1111/tid.12025 ID - Dirks2013 ER - TY - JOUR AU - Hofmann, L. AU - Forschner, A. AU - Loquai, C. AU - Goldinger, S. M. AU - Zimmer, L. AU - Ugurel, S. PY - 2016 DA - 2016// TI - Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy JO - Eur J Cancer VL - 60 UR - https://doi.org/10.1016/j.ejca.2016.02.025 DO - 10.1016/j.ejca.2016.02.025 ID - Hofmann2016 ER - TY - JOUR AU - Postow, M. A. AU - Sidlow, R. AU - Hellmann, M. D. PY - 2018 DA - 2018// TI - Immune-related adverse events associated with immune checkpoint blockade JO - N Engl J Med VL - 378 UR - https://doi.org/10.1056/NEJMra1703481 DO - 10.1056/NEJMra1703481 ID - Postow2018 ER - TY - STD TI - Haanen J, Carbonnel F, Robert C, Kerr KM, Peters S, Larkin J, et al. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl_4):iv119-iv42. ID - ref17 ER - TY - JOUR AU - De Velasco, G. AU - Je, Y. AU - Bosse, D. AU - Awad, M. M. AU - Ott, P. A. AU - Moreira, R. B. PY - 2017 DA - 2017// TI - Comprehensive meta-analysis of key immune-related adverse events from CTLA-4 and PD-1/PD-L1 inhibitors in Cancer patients JO - Cancer Immunol Res VL - 5 UR - https://doi.org/10.1158/2326-6066.CIR-16-0237 DO - 10.1158/2326-6066.CIR-16-0237 ID - De Velasco2017 ER - TY - JOUR AU - Influenza Vaccination, T. J. J. C. L. I. N. I. C. A. L. P. R. A. C. T. I. C. E. PY - 2016 DA - 2016// JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMcp1512870 DO - 10.1056/NEJMcp1512870 ID - Influenza Vaccination2016 ER - TY - JOUR AU - Robin, C. AU - Beckerich, F. AU - Cordonnier, C. PY - 2015 DA - 2015// TI - Immunization in cancer patients: where we stand JO - Pharmacol Res VL - 92 UR - https://doi.org/10.1016/j.phrs.2014.10.002 DO - 10.1016/j.phrs.2014.10.002 ID - Robin2015 ER - TY - JOUR AU - Sanei, F. AU - Wilkinson, T. PY - 2016 DA - 2016// TI - Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness JO - Ther Adv Respir Dis VL - 10 UR - https://doi.org/10.1177/1753465816646050 DO - 10.1177/1753465816646050 ID - Sanei2016 ER - TY - JOUR AU - Choi, D. K. AU - Fuleihan, R. L. AU - Walterhouse, D. O. PY - 2016 DA - 2016// TI - Serologic response and clinical efficacy of influenza vaccination in children and young adults on chemotherapy for cancer JO - Pediatr Blood Cancer VL - 63 UR - https://doi.org/10.1002/pbc.26110 DO - 10.1002/pbc.26110 ID - Choi2016 ER - TY - JOUR AU - Nakashima, K. AU - Aoshima, M. AU - Ohfuji, S. AU - Suzuki, K. AU - Katsurada, M. AU - Katsurada, N. PY - 2017 DA - 2017// TI - Immunogenicity of trivalent influenza vaccine in patients with lung cancer undergoing anticancer chemotherapy JO - Hum Vaccin Immunother VL - 13 UR - https://doi.org/10.1080/21645515.2016.1246094 DO - 10.1080/21645515.2016.1246094 ID - Nakashima2017 ER - TY - STD TI - Waqar SN, Boehmer L, Morgensztern D, Wang-Gillam A, Sorscher S, Lawrence S, et al. Immunogenicity of influenza vaccination in patients with Cancer. Am J Clin Oncol. 2015; ID - ref24 ER - TY - JOUR AU - Hakim, H. AU - Allison, K. J. AU - Van de Velde, L. A. AU - Tang, L. AU - Sun, Y. AU - Flynn, P. M. PY - 2016 DA - 2016// TI - Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection JO - Vaccine VL - 34 UR - https://doi.org/10.1016/j.vaccine.2016.04.053 DO - 10.1016/j.vaccine.2016.04.053 ID - Hakim2016 ER - TY - JOUR AU - Jamshed, S. AU - Walsh, E. E. AU - Dimitroff, L. J. AU - Santelli, J. S. AU - Falsey, A. R. PY - 2016 DA - 2016// TI - Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: a pilot randomized clinical trial JO - Vaccine VL - 34 UR - https://doi.org/10.1016/j.vaccine.2015.12.037 DO - 10.1016/j.vaccine.2015.12.037 ID - Jamshed2016 ER - TY - STD TI - Webster R, Cox N, Stöhr K. World Health Organization. Dept. of epidemic and pandemic alert and response. WHO manual on animal influenza diagnosis and surveillance. 2002. ID - ref27 ER - TY - JOUR AU - Erickson, J. J. AU - Rogers, M. C. AU - Hastings, A. K. AU - Tollefson, S. J. AU - Williams, J. V. PY - 2014 DA - 2014// TI - Programmed death-1 impairs secondary effector lung CD8(+) T cells during respiratory virus reinfection JO - J Immunol VL - 193 UR - https://doi.org/10.4049/jimmunol.1302208 DO - 10.4049/jimmunol.1302208 ID - Erickson2014 ER - TY - JOUR AU - Finnefrock, A. C. AU - Tang, A. AU - Li, F. AU - Freed, D. C. AU - Feng, M. AU - Cox, K. S. PY - 2009 DA - 2009// TI - PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination JO - J Immunol VL - 182 UR - https://doi.org/10.4049/jimmunol.182.2.980 DO - 10.4049/jimmunol.182.2.980 ID - Finnefrock2009 ER - TY - JOUR AU - Channappanavar, R. AU - Twardy, B. S. AU - Suvas, S. PY - 2012 DA - 2012// TI - Blocking of PDL-1 interaction enhances primary and secondary CD8 T cell response to herpes simplex virus-1 infection JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0039757 DO - 10.1371/journal.pone.0039757 ID - Channappanavar2012 ER - TY - JOUR AU - Mueller, S. N. AU - Vanguri, V. K. AU - Ha, S. J. AU - West, E. E. AU - Keir, M. E. AU - Glickman, J. N. PY - 2010 DA - 2010// TI - PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice JO - J Clin Invest VL - 120 UR - https://doi.org/10.1172/JCI40040 DO - 10.1172/JCI40040 ID - Mueller2010 ER - TY - JOUR AU - Bersanelli, M. AU - Castrignano, P. AU - Gambale, E. AU - Cortellini, A. AU - Tiseo, M. AU - Natoli, C. PY - 2017 DA - 2017// TI - Influenza Vaccine Indication During anticancer therapy with Immune-checkpoint inhibitors: a transversal challenge for patient’s counselling JO - Ann Oncol VL - 28 UR - https://doi.org/10.1093/annonc/mdx711.039 DO - 10.1093/annonc/mdx711.039 ID - Bersanelli2017 ER - TY - JOUR AU - Lo Russo, G. AU - Crino, L. AU - Galetta, D. AU - Ardizzoni, A. AU - Cortesi, E. AU - Cappuzzo, F. PY - 2017 DA - 2017// TI - Nivolumab in never smoker patients with advanced squamous NSCLC: results from the italian expanded access programme (EAP) JO - J Thorac Oncol VL - 12 UR - https://doi.org/10.1016/j.jtho.2016.11.491 DO - 10.1016/j.jtho.2016.11.491 ID - Lo Russo2017 ER - TY - JOUR AU - Wolchok, J. D. AU - Chiarion-Sileni, V. AU - Gonzalez, R. AU - Rutkowski, P. AU - Grob, J. J. AU - Cowey, C. L. PY - 2017 DA - 2017// TI - Overall survival with combined Nivolumab and Ipilimumab in advanced melanoma JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1709684 DO - 10.1056/NEJMoa1709684 ID - Wolchok2017 ER - TY - JOUR AU - Schenk, E. L. PY - 2017 DA - 2017// TI - Clinical outcomes of patients on check point inhibitor therapy who receive routine vaccinations JO - J Clin Oncol VL - 35 UR - https://doi.org/10.1200/JCO.2017.35.15_suppl.e14597 DO - 10.1200/JCO.2017.35.15_suppl.e14597 ID - Schenk2017 ER - TY - JOUR AU - June, C. H. AU - Warshauer, J. T. AU - Bluestone, J. A. PY - 2017 DA - 2017// TI - Is autoimmunity the Achilles' heel of cancer immunotherapy? JO - Nat Med VL - 23 UR - https://doi.org/10.1038/nm.4321 DO - 10.1038/nm.4321 ID - June2017 ER - TY - JOUR AU - Tocheva, A. S. AU - Mor, A. PY - 2017 DA - 2017// TI - Checkpoint inhibitors: applications for autoimmunity JO - Curr Allergy Asthma Rep VL - 17 UR - https://doi.org/10.1007/s11882-017-0740-z DO - 10.1007/s11882-017-0740-z ID - Tocheva2017 ER - TY - JOUR AU - Dong, H. AU - Chen, L. PY - 2003 DA - 2003// TI - B7-H1 pathway and its role in the evasion of tumor immunity JO - J Mol Med (Berl) VL - 81 UR - https://doi.org/10.1007/s00109-003-0430-2 DO - 10.1007/s00109-003-0430-2 ID - Dong2003 ER - TY - JOUR AU - Enamorado, M. AU - Iborra, S. AU - Priego, E. AU - Cueto, F. J. AU - Quintana, J. A. AU - Martinez-Cano, S. PY - 2017 DA - 2017// TI - Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8(+) T cells JO - Nat Commun VL - 8 UR - https://doi.org/10.1038/ncomms16073 DO - 10.1038/ncomms16073 ID - Enamorado2017 ER - TY - JOUR AU - Oh, D. Y. AU - Cham, J. AU - Zhang, L. AU - Fong, G. AU - Kwek, S. S. AU - Klinger, M. PY - 2017 DA - 2017// TI - Immune toxicities Elicted by CTLA-4 blockade in Cancer patients are associated with early diversification of the T-cell repertoire JO - Cancer Res VL - 77 UR - https://doi.org/10.1158/0008-5472.CAN-16-2324 DO - 10.1158/0008-5472.CAN-16-2324 ID - Oh2017 ER - TY - JOUR AU - Subudhi, S. K. AU - Aparicio, A. AU - Gao, J. AU - Zurita, A. J. AU - Araujo, J. C. AU - Logothetis, C. J. PY - 2016 DA - 2016// TI - Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities JO - Proc Natl Acad Sci U S A VL - 113 UR - https://doi.org/10.1073/pnas.1611421113 DO - 10.1073/pnas.1611421113 ID - Subudhi2016 ER - TY - JOUR AU - Johnson, D. B. AU - Balko, J. M. AU - Compton, M. L. AU - Chalkias, S. AU - Gorham, J. AU - Xu, Y. PY - 2016 DA - 2016// TI - Fulminant myocarditis with combination immune checkpoint blockade JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1609214 DO - 10.1056/NEJMoa1609214 ID - Johnson2016 ER - TY - JOUR AU - Laubli, H. AU - Koelzer, V. H. AU - Matter, M. S. AU - Herzig, P. AU - Dolder Schlienger, B. AU - Wiese, M. N. PY - 2018 DA - 2018// TI - The T cell repertoire in tumors overlaps with pulmonary inflammatory lesions in patients treated with checkpoint inhibitors JO - Oncoimmunology VL - 7 UR - https://doi.org/10.1080/2162402X.2017.1386362 DO - 10.1080/2162402X.2017.1386362 ID - Laubli2018 ER - TY - JOUR AU - Bilen, M. A. AU - Subudhi, S. K. AU - Gao, J. AU - Tannir, N. M. AU - Tu, S. M. AU - Sharma, P. PY - 2016 DA - 2016// TI - Acute rhabdomyolysis with severe polymyositis following ipilimumab-nivolumab treatment in a cancer patient with elevated anti-striated muscle antibody JO - J Immunother Cancer VL - 4 UR - https://doi.org/10.1186/s40425-016-0139-8 DO - 10.1186/s40425-016-0139-8 ID - Bilen2016 ER - TY - JOUR AU - Laubli, H. AU - Hench, J. AU - Stanczak, M. AU - Heijnen, I. AU - Papachristofilou, A. AU - Frank, S. PY - 2017 DA - 2017// TI - Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade JO - J Immunother Cancer. VL - 5 UR - https://doi.org/10.1186/s40425-017-0249-y DO - 10.1186/s40425-017-0249-y ID - Laubli2017 ER - TY - JOUR AU - Moise, L. AU - Beseme, S. AU - Tassone, R. AU - Liu, R. AU - Kibria, F. AU - Terry, F. PY - 2016 DA - 2016// TI - T cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunity JO - Expert Rev Vaccines VL - 15 UR - https://doi.org/10.1586/14760584.2016.1123098 DO - 10.1586/14760584.2016.1123098 ID - Moise2016 ER - TY - JOUR AU - van der Burg, S. H. AU - Arens, R. AU - Ossendorp, F. AU - van Hall, T. AU - Melief, C. J. PY - 2016 DA - 2016// TI - Vaccines for established cancer: overcoming the challenges posed by immune evasion JO - Nat Rev Cancer VL - 16 UR - https://doi.org/10.1038/nrc.2016.16 DO - 10.1038/nrc.2016.16 ID - van der Burg2016 ER - TY - JOUR AU - Kamphorst, A. O. AU - Ahmed, R. PY - 2013 DA - 2013// TI - Manipulating the PD-1 pathway to improve immunity JO - Curr Opin Immunol VL - 25 UR - https://doi.org/10.1016/j.coi.2013.03.003 DO - 10.1016/j.coi.2013.03.003 ID - Kamphorst2013 ER - TY - JOUR AU - Karyampudi, L. AU - Lamichhane, P. AU - Scheid, A. D. AU - Kalli, K. R. AU - Shreeder, B. AU - Krempski, J. W. PY - 2014 DA - 2014// TI - Accumulation of memory precursor CD8 T cells in regressing tumors following combination therapy with vaccine and anti-PD-1 antibody JO - Cancer Res VL - 74 UR - https://doi.org/10.1158/0008-5472.CAN-13-2564 DO - 10.1158/0008-5472.CAN-13-2564 ID - Karyampudi2014 ER - TY - JOUR AU - Ha, S. J. AU - Mueller, S. N. AU - Wherry, E. J. AU - Barber, D. L. AU - Aubert, R. D. AU - Sharpe, A. H. PY - 2008 DA - 2008// TI - Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection JO - J Exp Med VL - 205 UR - https://doi.org/10.1084/jem.20071949 DO - 10.1084/jem.20071949 ID - Ha2008 ER - TY - JOUR AU - Duraiswamy, J. AU - Kaluza, K. M. AU - Freeman, G. J. AU - Coukos, G. PY - 2013 DA - 2013// TI - Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors JO - Cancer Res VL - 73 UR - https://doi.org/10.1158/0008-5472.CAN-12-4100 DO - 10.1158/0008-5472.CAN-12-4100 ID - Duraiswamy2013 ER - TY - STD TI - Hu Z, Ott PA, Wu CJ. Towards personalized, tumour-specific, therapeutic vaccines for cancer. Nat Rev Immunol. 2017; ID - ref52 ER - TY - JOUR AU - Ott, P. A. AU - Hu, Z. AU - Keskin, D. B. AU - Shukla, S. A. AU - Sun, J. AU - Bozym, D. J. PY - 2017 DA - 2017// TI - An immunogenic personal neoantigen vaccine for patients with melanoma JO - Nature VL - 547 UR - https://doi.org/10.1038/nature22991 DO - 10.1038/nature22991 ID - Ott2017 ER - TY - JOUR AU - Sahin, U. AU - Derhovanessian, E. AU - Miller, M. AU - Kloke, B. P. AU - Simon, P. AU - Lower, M. PY - 2017 DA - 2017// TI - Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer JO - Nature VL - 547 UR - https://doi.org/10.1038/nature23003 DO - 10.1038/nature23003 ID - Sahin2017 ER - TY - JOUR AU - Hajjar, L. A. AU - Mauad, T. AU - Galas, F. R. AU - Kumar, A. AU - da Silva, L. F. AU - Dolhnikoff, M. PY - 2010 DA - 2010// TI - Severe novel influenza a (H1N1) infection in cancer patients JO - Ann Oncol VL - 21 UR - https://doi.org/10.1093/annonc/mdq254 DO - 10.1093/annonc/mdq254 ID - Hajjar2010 ER -